Brief: Nymox Pharma files its Q3 and restated Q2 2015 financial statements
31/12/2015 21:46
Dec 31 (Reuters) - Nymox Pharmaceutical Corp NYMX.O : * Says has filed its third quarter 2015 and restated second quarter 2015 financial statements * Restatement of Q2 2015 was required in order to correct a material accounting error in stock option compensation expense * Source text for Eikon ID:nGNXMIZLDa * Further company coverage NYMX.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Nymox Pharmaceutical
See all newsBrief: Nymox Says Required To Resubmit Application To DKMA
Brief: Nymox Pharmaceutical Corp Says Terminated Employment Of Christopher R Riley As CFO (June 27)
Brief: Nymox Announces Appointment Of Christopher R. Riley As Chief Financial Officer
Brief: Nymox Appeals Deficiency Letter
U.S. STOCKS ON THE MOVE-Pot stocks, Nymox, Zynerba